ArticleFrontiers in pharmacology2025

Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks.

Hiroshi Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.